Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115410) titled 'A single-arm phase II clinical trial of HIPEC in combination with CRS and durvalumab for the treatment of biliary tract tumors with peritoneal metastases' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Third Affiliated Hospital of Naval Medical University
Condition:
Biliary tract cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: HIPEC combined with CRS and durvalumab treatment group:33;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297768
Pu...